Hims & Hers Health Stock Soared This Week: Here's Why [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
and streamlined seems to still be riding high on its recent announcement of adding weight loss drugs to its product portfolio. The stock is up 55% in the past month and over 117% in the last 12 months. Betting on weight loss drugs On May 20, Hims & Hers announced it would be launching its own branded GLP-1 medicines. These are the revolutionary weight loss drugs that have been taking the globe by storm, due to the fact they are apparently effective in getting people to lose weight. However, Hims & Hers' are coming to the market at a relatively cheap price of $199 a month compared to the $1,000 current patients of GLP-1 products might be paying. These type of disruptive prices are what has made the company grow in popularity in recent years with other forms of drugs. It now wants to replicate this success with its weight loss portfolio. By 2025, management is expecting the weight loss division to hit $100 million in revenue. Innovative products and go-to-market strategies hav
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers defended at BofA as Lilly fights compounded GLP-1s [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $22.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $17.25 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- The Ultimate Growth Stock to Buy With $20 Right Now [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 6/20/24 - Form 144
- 6/18/24 - Form 4
- 6/18/24 - Form 4
- HIMS's page on the SEC website